L
Lorenzo G. Mantovani
Researcher at University of Milan
Publications - 361
Citations - 38356
Lorenzo G. Mantovani is an academic researcher from University of Milan. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 51, co-authored 324 publications receiving 26740 citations. Previous affiliations of Lorenzo G. Mantovani include University of Naples Federico II & University of Milano-Bicocca.
Papers
More filters
Journal ArticleDOI
Patient-reported outcomes associated with switching to rivaroxaban for the treatment of venous thromboembolism (VTE) in patients with active cancer
A. T. Cohen,Anthony Maraveyas,Jan Beyer‐Westendorf,Agnes Y.Y. Lee,Lorenzo G. Mantovani,Kerstin Folkerts,Miriam Bach,Y. De Sanctis,K. Abdelgawad +8 more
TL;DR: Patients with CAT reported a durable improvement in anticoagulation-associated treatment satisfaction, specifically a reduction in the perceived burdens of therapy, following the switch from a LMWH or VKA to rivaroxaban.
Journal ArticleDOI
Patients' and physicians' needs, experiences and preferences in the treatment of right ventricular outflow tract dysfunction
Luciana Scalone,Mario Carminati,Philipp Bonhoeffer,Paolo Cortesi,Lorenzo G. Mantovani,Giancarlo Cesana,John Hess +6 more
TL;DR: To optimize benefits and efficiency of the treatment strategies, perceptions and opinions from the different subjects involved, together with patients’ clinical needs and overall costs, should be considered in decision-making.
Journal ArticleDOI
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study
Ippazio Cosimo Antonazzo,Carla Fornari,Davide Rozza,Sara Conti,R. Di Pasquale,Paolo Cortesi,Shaniko Kaleci,Pietro Ferrara,Alberto Zucchi,Giovanni Maifredi,Andrea Silenzi,Giancarlo Cesana,Lorenzo G. Mantovani,Giampiero Mazzaglia +13 more
TL;DR: The role of statins among patients with established cardiovascular diseases (CVDs) who are hospitalized with COVID-19 is still debated as mentioned in this paper , and the prior use of statin exposure was associated with a less severe CoV-19 prognosis.